<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/~/media/Files/V/Valeant-IR/XSL/rss_xsl.xsl"?> 
<rss version="2.0" xmlns:dt="http://xsltsl.org/date-time">
 <channel>
  <title>RSS - Valeant-IR News Releases</title>
  <link>https://www.ir.bauschhealth.com/news-releases</link>
  <language>en</language>
<webMaster>Valeant</webMaster>
<image>
<url>https://www.ir.bauschhealth.com/~/media/Images/V/Valeant-IR/logo/logo-rss.jpg</url>
</image>
<item>
<title><![CDATA[Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/10-06-2026-120140859</link>
<pubDate>Tue, 06 Oct 2026 12:00:00 GMT</pubDate>
<publishDate>Tue, 06 Oct 2026 12:03:24 GMT</publishDate>
<guid>{B4CC2DF0-6087-43F9-8572-00FB691D6144}</guid>
<isalertable>True</isalertable>
</item>
<item>
<title><![CDATA[Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/09-08-2026-130256785</link>
<pubDate>Tue, 08 Sep 2026 13:00:00 GMT</pubDate>
<publishDate>Tue, 08 Sep 2026 13:21:27 GMT</publishDate>
<guid>{7219B533-AA5C-4CF3-8536-5B5EA13BD37F}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[<sup>Pr</sup>SILIQ<sup>®</sup> (brodalumab injection) Now Reimbursed Under Alberta’s Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/09-08-2026</link>
<pubDate>Tue, 08 Sep 2026 12:00:00 GMT</pubDate>
<publishDate>Tue, 08 Sep 2026 12:00:05 GMT</publishDate>
<guid>{A527537B-07DE-4C8A-8FE3-37D8E9E0EE1F}</guid>
<isalertable>True</isalertable>
</item>
<item>
<title><![CDATA[Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/09-01-2026-130559061</link>
<pubDate>Tue, 01 Sep 2026 13:01:00 GMT</pubDate>
<publishDate>Tue, 01 Sep 2026 13:06:54 GMT</publishDate>
<guid>{A2F65A4B-6FC8-4EE3-B843-39A979BC94F4}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[Bausch Health Announces Availability of Solta Medical’s Fraxel FTX<sup>®</sup> in Australia (Australia Version) ]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/08-31-2026</link>
<pubDate>Mon, 31 Aug 2026 23:00:00 GMT</pubDate>
<publishDate>Fri, 04 Sep 2026 22:53:26 GMT</publishDate>
<guid>{374E37E4-E38C-4CD2-AB48-1D7920CA0113}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/08-27-2026-130342499</link>
<pubDate>Thu, 27 Aug 2026 13:02:00 GMT</pubDate>
<publishDate>Thu, 27 Aug 2026 13:20:44 GMT</publishDate>
<guid>{1CD6CA2C-24D3-415F-B7D2-3944099CF686}</guid>
<isalertable>True</isalertable>
</item>
<item>
<title><![CDATA[Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/08-17-2026-130154155</link>
<pubDate>Mon, 17 Aug 2026 13:00:00 GMT</pubDate>
<publishDate>Mon, 17 Aug 2026 13:03:07 GMT</publishDate>
<guid>{1D5761EF-C1D6-40E1-ABC6-D8E93CB4736F}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/08-06-2026-120504328</link>
<pubDate>Thu, 06 Aug 2026 12:04:00 GMT</pubDate>
<publishDate>Thu, 06 Aug 2026 12:09:46 GMT</publishDate>
<guid>{E54DDF69-4A8A-4650-A698-CE4137FE2A0E}</guid>
<isalertable>True</isalertable>
</item>
<item>
<title><![CDATA[Bausch Health Announces Second Quarter 2026 Results, Raises Guidance]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/07-29-2026</link>
<pubDate>Wed, 29 Jul 2026 21:05:00 GMT</pubDate>
<publishDate>Wed, 29 Jul 2026 21:07:28 GMT</publishDate>
<guid>{E098749E-ABF6-40BF-AA18-6E2B22C07D3D}</guid>
<isalertable>True</isalertable>
</item>
<item>
<title><![CDATA[<sup>Pr</sup>ELIDEL<sup>®</sup> (pimecrolimus) cream Now Reimbursed Under Alberta’s Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis]]></title>
<link>https://www.ir.bauschhealth.com/news-releases/2026/07-28-2026</link>
<pubDate>Tue, 28 Jul 2026 13:00:00 GMT</pubDate>
<publishDate>Tue, 28 Jul 2026 13:00:17 GMT</publishDate>
<guid>{336B233D-F777-4F30-9D9B-4BCE0A3ECA9A}</guid>
<isalertable>True</isalertable>
</item>

  
 </channel>
</rss>